Anticancer Drug Development: Preclinical Screening, Clinical Trials and Approval

被引：0
|
作者：
D Selwood
机构：
[1] Wolfson Institute for Biomedical Research,
[2] University College,undefined
来源：
British Journal of Cancer | 2004年 / 91卷 / 5期
关键词：
D O I：
10.1038/sj.bjc.6602070
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1000 / 1000
相关论文
共 50 条
  • [1] Erratum: Anticancer drug development: preclinical screening, clinical trials and approval
    B A Teicher
    D L Selwood
    P A Andrews
    British Journal of Cancer, 2004, 91 : 1977 - 1977
  • [2] Anticancer drug development: preclinical screening, clinical trials and approval (vol 91, pg 1000, 2004)
    Teicher, BA
    Selwood, DL
    Andrews, PA
    BRITISH JOURNAL OF CANCER, 2004, 91 (11) : 1977 - 1977
  • [3] CYTOSTATIC ANTICANCER DRUG DEVELOPMENT - PRECLINICAL STUDIES AND EARLY CLINICAL-TRIALS
    FIEBIG, HH
    BERDEL, WE
    QUEISSER, W
    ONKOLOGIE, 1990, 13 (01): : 57 - 60
  • [4] Clinical approval: Trials of an anticancer jab
    Julie Clayton
    Nature, 2012, 488 : S4 - S6
  • [5] CLINICAL APPROVAL Trials of an anticancer jab
    Clayton, Julie
    NATURE, 2012, 488 (7413) : S4 - S6
  • [6] Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
    Bruinsmann, Franciele Aline
    Vaz, Gustavo Richter
    Soares Alves, Aline de Cristo
    Aguirre, Tanira
    Pohlmann, Adriana Raffin
    Guterres, Silvia Staniscuaski
    Sonvico, Fabio
    MOLECULES, 2019, 24 (23):
  • [7] CYTOSTATIC ANTICANCER DRUG DEVELOPMENT - PRECLINICAL STUDIES AND EARLY CLINICAL-TRIALS (FRANKFURT MAIN, NOVEMBER 1989)
    BERDEL, WE
    FIEBIG, HH
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (02) : 224 - 227
  • [8] Post-hoc power of clinical trials supporting anticancer drug approval by FDA.
    Nadler, Michelle
    Desnoyers, Alexandra
    Saleh, Ramy
    Amir, Eitan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] PRAGMATIC CLINICAL TRIALS FOR DRUG APPROVAL: IS IT REALISTIC?
    Mohr, P.
    Sonnad, S.
    Mullins, C. D.
    Whicher, D.
    Goldsack, J.
    Tunis, S. R.
    VALUE IN HEALTH, 2010, 13 (03) : A3 - A3
  • [10] CLINICAL TRIALS: THEIR PHASES AND RELEVANCE FOR DRUG APPROVAL
    Le Bars, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 37 - 37
12345